近日，由(you)市(shi)(shi)(shi)中(zhong)(zhong)(zhong)藥(yao)(yao)研(yan)究(jiu)院承(cheng)擔(dan)的(de)(de)“重(zhong)慶(qing)市(shi)(shi)(shi)藥(yao)(yao)物安全(quan)評(ping)價(jia)(jia)中(zhong)(zhong)(zhong)心(xin)（GLP中(zhong)(zhong)(zhong)心(xin)）能力(li)(li)提(ti)升建設(she)(she)”項(xiang)(xiang)目通過市(shi)(shi)(shi)科委組織的(de)(de)專家(jia)驗(yan)收。“重(zhong)慶(qing)市(shi)(shi)(shi)藥(yao)(yao)物安全(quan)評(ping)價(jia)(jia)中(zhong)(zhong)(zhong)心(xin)（GLP中(zhong)(zhong)(zhong)心(xin)）”依托市(shi)(shi)(shi)中(zhong)(zhong)(zhong)藥(yao)(yao)研(yan)究(jiu)院建設(she)(she)，于(yu)2009年和2013年兩次通過國家(jia)GLP認證(zheng)，是西南地區首家(jia)藥(yao)(yao)物安全(quan)評(ping)價(jia)(jia)中(zhong)(zhong)(zhong)心(xin)，也(ye)是我市(shi)(shi)(shi)唯(wei)一獲(huo)得(de)(de)國家(jia)認證(zheng)的(de)(de)藥(yao)(yao)物安全(quan)評(ping)價(jia)(jia)機構。通過“重(zhong)慶(qing)市(shi)(shi)(shi)GLP中(zhong)(zhong)(zhong)心(xin)能力(li)(li)提(ti)升建設(she)(she)”項(xiang)(xiang)目的(de)(de)實(shi)施，該中(zhong)(zhong)(zhong)心(xin)綜合服務(wu)能力(li)(li)得(de)(de)到顯著(zhu)提(ti)升：一是完(wan)善了(le)(le)(le)中(zhong)(zhong)(zhong)心(xin)的(de)(de)硬件(jian)設(she)(she)施，完(wan)成(cheng)各類控(kong)制系統、設(she)(she)施改造10余(yu)項(xiang)(xiang)，購(gou)置各類儀器(qi)119臺(tai)/套，儀器(qi)更新(xin)率達(da)40%。二是建立了(le)(le)(le)管理(li)運行(xing)機制，制定、修訂各類規章制度435條，管理(li)運行(xing)更加(jia)規范(fan)。三(san)是形成(cheng)了(le)(le)(le)相(xiang)關技術(shu)(shu)(shu)體(ti)系，先后建立4項(xiang)(xiang)未認證(zheng)項(xiang)(xiang)目安全(quan)評(ping)價(jia)(jia)研(yan)究(jiu)技術(shu)(shu)(shu)規范(fan)和痛風(feng)等(deng)4種重(zhong)大疾(ji)病藥(yao)(yao)效學評(ping)價(jia)(jia)技術(shu)(shu)(shu)體(ti)系，突破(po)關鍵技術(shu)(shu)(shu)30余(yu)項(xiang)(xiang)。四是提(ti)升了(le)(le)(le)新(xin)藥(yao)(yao)研(yan)發(fa)能力(li)(li)，成(cheng)功培育了(le)(le)(le)一支(zhi)創新(xin)藥(yao)(yao)物安全(quan)評(ping)價(jia)(jia)專業(ye)團隊，開展了(le)(le)(le)3種自(zi)主(zhu)新(xin)藥(yao)(yao)及31種委托新(xin)藥(yao)(yao)安全(quan)評(ping)價(jia)(jia)研(yan)究(jiu)，獲(huo)得(de)(de)臨床批件(jian)6個(ge)、發(fa)明專利授權2件(jian)、發(fa)表論(lun)文46篇。